Gold vs US Dollar

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Cartesian Therapeutics Inc (RNAC)
Cartesian Therapeutics Inc (RNAC) Financials

RNAC Cartesian Therapeutics Inc

19.88

1.41 (7.63%)

After Hours

Last Updated: 22:37:11

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-61.723	-68.614	-89.758	-76.848	-51.981	-15.792	21.72	-93.308
Return on Equity (%)	132.527	-122.357	-281.645	-3716.012	1433.573	-1137.852	60.815	126.869
Return on Invested Capital (%)	157.505	-94.479	-194.589	-7941.711	-942.618	-76.748	20.061	365.76
Operating Margin (%)	-432.476	-30973.43	-7069.989	-806.215	-405.615	-8.083	34.124	-907.08
Net Profit Margin (%)	-504.466	-31556.039	-7235.437	-828.965	-414.991	-30.193	31.937	-844.908
Book Value Per Share	2.98	2.319	-0.241	0.097	-0.167	0.182	0.613	-2.18
Earnings Per Share	-2.211	-2.924	-2.907	-0.641	-0.637	-0.208	0.231	-1.416
Cash Per Share	3.181	3.161	1.664	1.041	1.283	0.923	0.695	0.496
Working Capital Per Share	3.965	3.925	0.308	0.715	0.646	0.584	0.804	0.145
Operating Profit Per Share	0.438	0.009	0.04	0.077	0.154	0.688	0.724	0.168
EBIT Per Share	-1.964	-2.924	-2.907	-0.641	-0.637	-0.079	0.227	-1.538
EBITDA Per Share	-1.964	-2.924	-2.907	-0.641	-0.637	-0.079	0.227	-1.538
Free Cash Flow Per Share	-2.223	-2.927	-2.913	-0.649	-0.637	-0.204	0.234	-1.42

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	18.44M	22.34M	22.47M	86.33M	108.07M	123.62M	153.04M	N/A

Key Stats and Ratios

Year End 31 December 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	153.03M	153.04M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	-351.213	N/A	N/A	N/A	-973.014	N/A
Net Profit Margin (%)	N/A	N/A	-364.82	N/A	N/A	N/A	-973.014	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	469.41M
Price to Earnings Ratio	-2.3
Price to Sales Ratio	19.47
Price to Cash Ratio	6.58
Price to Book Ratio	-3.63
Dividend Yield	-

Share Statistics

Shares Outstanding	25.41M
Average Volume (1 week)	270.86k
Average Volume (1 Month)	165.99k
52 Week Change	-9.84%
52 Week High	41.87
52 Week Low	11.665

More Ratios Coming Soon!

Cartesian Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions